Human noroviruses (NoVs) are causative agents of nonbacterial acute gastroenteritis, second only to rotaviruses, in all age groups of humans and are associated with significant morbidity worldwide and substantial mortality in developing countries (12, 15, 21, 25) . They belong to the genus Norovirus in the family Caliciviridae. The rates of infection with NoVs are high, and the viruses spread rapidly from person to person primarily via the fecal-oral route, resulting in large outbreaks of disease that often persist. The magnitude of genetic and antigenic diversity among NoV strains came to light in the past several years due to greater surveillance of disease outbreaks and rapid availability and analysis of sequence data (1, 12, 13, 24, 38, 41) . The NoV strains that infect humans are classified into two major genogroups, genogroup I (GI) and GII. The GII strains exhibit greater virulence, as they are prone to undergo recombination, and they cause the majority of gasteroenteritis worldwide (14, 19, 22, 30, 31, 42) .
NoVs are spherical with a diameter of ϳ35 nm and contain a single-stranded, positive-sense, polyadenylated RNA genome of 7,400 to 7,700 nucleotides (2) . The genome is divided into three open reading frames (ORFs). ORF1 encodes a 200-kDa polyprotein, which is further processed into at least six nonstructural proteins. ORF2 codes for the ϳ60-kDa capsid protein (CP) VP1, and ORF3 encodes a minor structural protein, VP2, which is basic in nature (15, 28) . Studies on the life cycle and pathogenesis of NoVs have been hampered by the lack of an appropriate cell culture system. However, the ability to generate virus-like particles (VLPs) from insect cells infected with recombinant baculoviruses expressing the coat protein (VP1) and in vitro studies of binding to histo-blood group antigens has led to significant advances related to NoV structure, function, and biophysical properties (3, 7, 20, 29) .
The three-dimensional (3D) structures of Norwalk virus (NV) VLPs and San Miguel sea lion virus, a member of the genus Vesivirus (GII.2) in the family Caliciviridae, have been determined at near-atomic resolution (10, 29) . Typically, NV capsids are composed of 180 copies of a coat protein (VP1) assembled into T ϭ 3 icosahedral virions. However, it has been reported that sometimes VP1 subunits form smaller capsids, which consists of 60 subunits with T ϭ 1 icosahedral symmetry (40) . The tertiary structure of the NV capsid protein contains two major structural domains: the shell (S) domain with a canonical ␤-barrel fold and the protruding (P) domain. The S domain consists of the N-terminal 225 amino acids (aa), and the P domain is composed of 226 to 530 aa. The P domain is further divided into two subdomains, P1 and P2. The P1 domain comprises aa 226 to 278 and 406 to 530. The P2 domain is a 127-aa insertion (aa 279 to 405) in the P1 domain; it is the most distal part of the folded coat protein (VP1) and is located at the exterior surface of the capsid (29) . The P2 domain is therefore predicted to contain the antigenic determinants of the immunological response of the host. A binding surface that interacts with the human histo-blood group antigens was mapped onto the P2 domain by computational analysis and later confirmed by site-directed mutagenesis (35) . Recently, Lochridge et al. identified amino acids 291 to 293 and 313 to 322 as the likely antigenic epitopes in the P2 domains of NV and Snow Mountain virus, which are the reference strains of GI.1 and GII.2, respectively (23) . The linear epitope composed of amino acids 313 to 322 in Snow Mountain virus, which has been suggested to be responsible for the host cell interactions, is conserved among all the NoVs (23) .
Sequence analysis of the NoV capsid protein indicated that the S-domain sequences are about 30% identical, while the sequence identity drops to 11% and 8% in the P1 and P2 domains, respectively (9) . Even though there are many trypsin and chymotrypsin cleavage sites across the entire capsid protein, results obtained from the proteolytic analysis of the Norwalk virus VLPs clearly indicated that the intact NV particles are resistant to trypsin digestion (18) . However, trypsin digestion of the soluble protein of NV resulted in partial digestion of the capsid protein, in which the S domain was completely digested while the P domain remained intact (18) . These data indicated that the P-domain structure is resistant to proteases. However, recent studies by Tan et al. contradict the above results. In particular, they suggest that the intact particles of NV and VA387, a GII.4 virus, undergo partial trypsinization near the hinge region between the S and P domains, thereby releasing the nearly intact P domain of 32 to 34 kDa (36) .
Sinsiro virus (SV), the subject of the present study, belongs to the GII.3 NoVs. The capsid protein of SV is made of 548 aa residues and exhibits 98% amino acid sequence identity with other members of GII.3 NoVs (e.g., Arg320, Oberhausewn, and Toronto viruses, etc.). The prevalence of acute gastroenteritis caused by these strains suggested that they have better adaptability to circumvent the human immune response (27) . The molecular and structural characterization of SV VLPs may provide further insights into their pathogenesis. Here we report the results of studies on expression of the SV capsid protein in insect cells by using a recombinant baculovirus system, three-dimensional electron microscopy (EM) reconstruction using negatively stained particles, and homology modeling of the SV capsid. In addition, we characterized the unique trypsin cleavage pattern of SV by using N-terminal sequencing, mass spectrometry analysis, and molecular modeling studies. The sequence in and around the insertion is conserved among all GII.3 and GII.6 NoVs, suggesting that these viruses undergo similar patterns of trypsinization. The results from this study may provide some of the possible reasons for the greater efficacy of virus-cell interactions involving GII.3 and GII.6 NoVs.
MATERIALS AND METHODS
Homology modeling of the SV capsid. The comparative modeling program MODELLER (version 6.0) and the default modeling options (32) were used to generate homology models of Sinsiro virus. The Norwalk virus capsid structure (PDB no. 1IHM) was used as the template due to its having greater sequence identity (47%) than the San Miguel sea lion virus (PDB no. 2GH8), which has only 17% amino acid sequence identity with SV. The amino acid sequence identity of 47% between Sinsiro and Norwalk viruses is well above the threshold (35%) for obtaining a reliable homology model. A multiple-sequence alignment was obtained by aligning the amino acid sequences of 12 different NoVs, including Sinsiro virus, to the Norwalk virus sequence, using the Clustal-w server available at http://clustalw.genome.jp/. In addition, six neighboring subunits that immediately surround the three reference subunits (A, B, and C) (http://viperdb .scripps.edu/info_page.php?VDB ϭ 1ihm) (34) were included to impose restraints on the subunit interfaces. At the end of the modeling run, the reference subunits (A, B, and C) were extracted and used for the subsequent analysis.
Cell culture. Spodoptera frugiperda cells (line IPLB-Sf21) were grown at 27°C in TC100 medium (Invitrogen, Carlsbad, CA) supplemented with 0.35 g of NaHCO 3 per liter, 2.6 g of tryptose broth per liter, 2 mM L-glutamine (final concentration), 100 U of penicillin per ml, 100 g of streptomycin per ml, and 10% heat-inactivated fetal bovine serum (33) . Cultures were maintained as monolayers in screw-cap plastic flasks or as suspensions in 1-liter spinner flasks. Hi5 cells were grown at 27°C in ESF 921 medium (Expression System, CA) supplemented with 100 g of penicillin per ml and 100 g of streptomycin per ml. Cultures were maintained in suspension on a shaker (100 rpm) in a 500-ml polypropylene bottle.
Generation of recombinant baculoviruses expressing SV coat protein. The cDNA clone of Sinsiro virus capsid protein was generously provided to us by Shinichi Kobayashi (Aichi Prefectural Institute of Public Health, Nagoya, Japan) and used as a template in a PCR to amplify the full-length capsid gene (GenBank accession no. AB195226), using forward (5ЈCGGGATCCATGAAGATGGCG TCGAATG3Ј) and reverse (5ЈGCTCTAGATTATTGAATCCTTCTACGCCC A3Ј) primers having 5Ј BamHI and XbaI restriction sites, respectively. PCR was performed using high-fidelity Pfx polymerase (Invitrogen) according to the manufacturer's instructions. Recombinant baculovirus transfer plasmids (pBPSV) containing the full-length Sinsiro virus CP sequence were generated by inserting PCR-amplified fragments flanked by BamHI and XbaI restriction enzyme sites into the multiple cloning sites of pBacPAK9 (BD Biosciences-Clontech, CA). pBSV plasmids were sequenced using Bac1 (5ЈACCATCTCGCAAATAAATA 3Ј) and Bac2 (5ЈCAACGCACAGAATCTAGCG 3Ј) primers to confirm the accuracy of the SV sequence. Recombinant baculoviruses expressing SV CPs were generated by cotransfecting pBPSV plasmids with linearized baculovirus DNA (pBacPAK6) according to the manufacturer's instructions (BD Biosciences-Clontech). Recombinant baculoviruses were plaque purified and amplified to obtain pure stocks of viruses.
Expression and purification of rSV particles. Recombinant SV (rSV) particles were prepared and purified essentially as previously described (17) . Briefly, Trichoplusia ni (Tn5) insect cells (2.0 ϫ 10 6 cells per ml) were infected with a baculovirus recombinant expressing the capsid protein of SV at a multiplicity of infection of 5 and incubated for 3 days at 27°C in a incubator shaker maintained at 100 rpm. Nonidet P-40 was added to a final concentration of 0.5% (vol/vol) and incubated on ice for 10 min to lyse the cells. rSV particles released into the medium were separated from the cell lysate by centrifuging the culture for 15 min at 10,000 rpm in a JA-17 rotor, using a Beckman J2-21 centrifuge. The expressed protein in supernatant was concentrated by precipitation with polyethylene glycol (8%) and was further purified by centrifugation through a 30% (wt/wt) sucrose cushion for 2 h in an Ti 50.2 rotor (Beckman) at 35,000 rpm. Pellets were suspended in 0.1 M phosphate buffer (pH 6.0), layered onto 10 to 40% sucrose gradients, and centrifuged for 3 h at 26,000 rpm in an SW28 rotor. Peak fractions then were pooled, dialyzed, and stored at 4°C. Integrity of the rSV VLPs was confirmed by EM observation of particles negatively stained with 1% uranyl acetate. The protein concentrations were determined with a Bradford assay kit for quick protein estimation (Bio-Rad).
Native gel analysis. The purified VLPs were subjected to native gel analysis in 0.5% (wt/vol) agarose gels with 0.1 M Tris-malate buffer (pH 6.5) containing 0.001% (wt/vol) ethidium bromide. The electrophoresis was carried out at a constant voltage (40 V) for 3 h, and RNA was visualized in a Bio-Rad Gel Doc system. The gel was dried and stained for protein with 0.05% (wt/vol) Coomassie brilliant blue R250.
Isolation of RNA from purified particles and reverse transcription-PCR analysis. Sodium dodecyl sulfate (SDS) and NaCl were added to gradient-purified SV particles at final concentrations of 1% (wt/vol) and 0.2 M, respectively. RNA was extracted with an equal volume of acidic phenol-chloroform and precipitated with 3 volumes of ethanol in the presence of 0.3 M sodium acetate and 20 mg of glycogen. After several hours at Ϫ20°C, the RNA was pelleted, washed with 70% ethanol, dried, and dissolved in nuclease-free water, and first-strand cDNA synthesis was carried out using CP-specific antisense primers with reverse transcriptase (Invitrogen, CA). The PCR was performed using Pfx polymerase (Invitrogen, CA).
Production of hyperimmune antiserum in laboratory mice and ELISA. To produce hyperimmune serum, mice were immunized with rSV capsid protein.
The immunization regimen consisted of one intramuscular injection of the purified rSV in Freund's adjuvant (at a dose of 60 g per mouse) followed by two booster injections of the same dose in Freund's incomplete adjuvant. The animals were bled 2 weeks after the last booster injection. An enzyme-linked immunosorbent assay (ELISA) was performed to quantify the titer of antibody. Briefly, the VLPs were directly applied to microplates (nun-Immuno plates) at 100 l per well and a final concentration of 1 g/ml in carbonate-bicarbonate buffer (0.05 M, pH 9.6) and were incubated overnight at 4°C. The antigen-coated plates were blocked for 2 h at room temperature with 5% nonfat milk in 0.01 M phosphate-buffered saline (PBS) (pH 7.2) and washed thrice with PBS containing 0.05% Tween 20 (PBST). Different dilutions of primary antisera (1:10, 1:100, 1:1,000, and 1:10,000) were incubated with the antigen for 1 h at room temperature and washed thrice with PBST. Anti-mouse immunoglobulin (Sigma) was diluted 1:10,000, and the plates were incubated for 1 h at room temperature. Following incubation, the plates were washed thrice with PBST, 3,3Ј,5,5Ј-tetramethyl benzidine (TMB)-peroxidase substrate (Sigma) was added, and the color was allowed to develop for 10 min at room temperature. The reaction was stopped by adding 1% SDS, and the optical density at 405 nm was determined with a Spectra Max-250 (Molecular Devices, CA).
Trypsin digestion of assembled and solubilized rSV protein. TPCK (N-tosyl-L-phenylalanine chloromethyl ketone)-trypsin was purchased from Sigma-Aldrich. Stock solutions were prepared at concentrations of 2 mg/ml in 0.001 N HCl, and serial dilutions were made in PBS (pH 7.4). Digestions of rNV particles were performed for 30 min at 37°C in reaction volumes of 20 microliters. Following incubation, reaction products were electrophoresed on 4 to 12% bis-Tris gels (Invitrogen, CA), and bands were visualized by staining with Simple blue as described by the manufacturer (Invitrogen, CA). Disassociation of VLPs was performed by dialyzing rSV particles overnight at 4°C in 50 mM Tris (pH 8.9). Samples were also visualized under EM to confirm the disassembly of VLPs. Digestion of solubilized rSV protein was performed as described for the assembled particles.
Gradient purification of trypsin-digested rSV particles was done by treating the VLPs (1 mg/ml) with trypsin (62.5 g/ml) at 37°C for 30 min in a reaction volume of 1.0 ml. This was followed by layering 500 l of the digested VLPs on a continuous 10 to 40% sucrose gradient and centrifuging for 2 h in an SW41 rotor (Beckman), and fractions were collected by bottom puncture and analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis.
SDS-PAGE and immunoblotting analysis. Samples to be analyzed were boiled for 2 min in sample buffer containing 2% SDS, 100 mM dithiothreitol, 0.05 M Tris-HCl (pH 6.8), 10% glycerol, and 0.1% bromophenol blue. Proteins were analyzed on 4 to 12% bis-Tris gels according to the manufacturer's instructions (Invitrogen, CA). The proteins separated by SDS-PAGE were transferred onto a polyvinylidene difluoride (PVDF) membrane (Invitrogen, CA) as described by manufacturer. The full-length SV and trypsin-digested SV capsid protein were detected using a mouse hyperimmune anti-rSV serum at a dilution of 1:5,000 in PBS. The secondary antibodies used were conjugated to horseradish peroxidase (Chemicon International, CA). The membrane was developed with SuperSigna West Pico chemiluminescent substrate (Pierce Biotechnology, Inc., IL) according to the manufacturer's protocol.
Transmission EM (TEM). Negative-stain EM was used to analyze the presence, integrity, and morphology of the rSV VLPs. Uranyl acetate (1%; pH 5.0) was used to stain the samples. A drop of the sample (10 l) was placed on glow-discharged, carbon-coated, 400-mesh copper grids (Ted Pella Inc., Redding, CA) for 1 min at room temperature. The grids were washed three times by being transferred into drops of water placed on Parafilm, and the excess liquid was blotted off from the side of the grid with a filter paper. The grids were then stained by quickly immersing them (twice) into drops of uranyl acetate solution and finally were placed in a third drop of uranyl acetate stain for 1 min, and excess liquid was blotted out as before. The grids were then air dried for 5 min at room temperature and examined under a CM100 microscope (Phillips) at 80 kV at a magnification of ϫ45,000, and photographs were recorded at a magnification of ϫ52,000.
Reconstruction of negatively stained VLPs. The VLP samples at a concentration of 4 mg/ml were placed on glow-discharged carbon film and stained briefly with 2% uranyl acetate. The grids were observed in a Philips Tecnai F20 transmission electron microscope operated at 120 kV. Digital images were recorded using low-irradiation procedures (ϳ20 electrons/Å 2 ), and those that displayed minimal astigmatism and drift as assessed by visual inspection and diffraction were selected for further analysis. Particles separated from their neighbors and with a clear background were selected and masked as individual images by using the software ROBEM (6) . The image intensity values were adjusted to remove linear background gradients and to normalize the means and variances of the data (8) . The initial orientation and origin parameters of the images for the reconstruction were determined by a model-based refinement approach. An electron density map was calculated from the X-ray coordinates of Norwalk virus (PDB no. 1IHM) and used as an initial model. The translation (x, y) and orientation (0, 0, w) parameters were refined for each particle by use of repeated cycles of correlation procedures (4-6). Images were typically discarded if they showed a correlation coefficient, calculated between the raw image and the corresponding projected view of an intermediate reconstruction, of less than one standard deviation of the mean correlation coefficient of the entire data set. A complete refinement protocol was carried out using the EM3DR package (6) . The final maps were computed using a total of 184 individual particles.
Mass spectrometry and N-terminal amino acid protein sequence analysis. The molecular weights of protein were determined by matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry performed at the core facility of the Scripps Research Institute, CA. For N-terminal amino acid sequence analysis, proteins separated by SDS-PAGE were transferred onto a PVDF membrane and stained with Ponceau red, and the bands corresponding to the trypsin cleavage products, detected by Western blot analysis, were excised. N-terminal microsequencing was performed on an Applied Biosystems (ABI Procise) protein sequencer in the Protein Sequencing Core Facility at the Scripps Research Institute.
RESULTS
Production of recombinant SV VLPs by using the baculovirus expression system. A PCR-amplified 1.7-kb fragment (ORF2 of SV) was subcloned into a baculovirus transfer vector to produce a construct called pBPSV. Sequencing of pBPSV confirmed the presence and accuracy of the SV sequence. Recombinant baculoviruses expressing the coat protein of SV were isolated by transfecting the Sf21 cells with pBPSV and linearized genomic DNA, followed by plaque purification. Electrophoretic analysis of the overexpressed proteins from the infected cells showed a major band with an apparent molecular mass of 60 kDa (data not shown). Recombinant Sinsiro virus VLPs were further purified by banding on a 10% to 40% sucrose gradient, and the peak fractions were collected. SDS-PAGE analysis of the fractions highlighted the presence of a single major band of ϳ60 kDa (Fig. 1A) . Examination of the major peak fraction (Fig. 1A, lane 6 ) under a transmission electron microscope by employing negative-staining procedures confirmed the presence of intact particles (Fig. 1B) . These particles resembled the typical NoV particles produced in earlier studies (20) . We observed mostly empty particles, as seen in the case of NV VLPs, and a few full particles having an average diameter of ϳ35.0 nm. However, the relative proportions of the full and empty particles varied from one preparation to another and also depended on the type of insect cells (e.g., Sf21 or Tn5) used for the baculovirus expression. Although the formation of full capsids is not a very common observation, such a finding has been reported earlier in the case of Hawaii human calicivirus (GII) (16) . The gradientpurified rSV particles were used for immunizing mice. The serum samples collected from the mice showed high titers of antibodies against rSV as evaluated by ELISA (data not shown).
EM reconstruction of negatively stained rSV capsids. Since our efforts to obtain good frozen cryosamples had not been very successful so far, a preliminary 3D reconstruction of VLPs was carried out using 186 negatively stained particles, which adequately sampled the icosahedral asymmetric unit to a resolution of 26 Å. The reconstruction clearly showed that the subunits are organized in a T ϭ 3 icosahedral arrangement with a thin contiguous shell and distinctive protrusions on the VOL. 81, 2007 SURFACE-EXPOSED LOOP FACILITATES TRYPSINIZATION OF SV 1121 surface ( Fig. 2A and B) . A comparative analysis of this reconstruction with the 3D structure of the recombinant Norwalk virus (PDB-ID no. 1IHM) (29) showed no discernible differences at this resolution. The relative dispositions of the shell and the protruding domains appeared identical to those of Norwalk virus.
Characterization of RNA associated with VLPs. Purified rSV VLPs were analyzed on a native 0.5% agarose gel and stained with ethidium bromide to visualize the presence of RNA. The same gel was dried and stained for protein with Coomassie brilliant blue R-250. Interestingly, the VLPs stained positive for both RNA and protein ( Fig. 3A and B) . This was rather surprising, as we saw mostly empty particles under the electron microscope (Fig. 1B) . First-strand cDNA synthesis of the RNA isolated from the VLPs with murine leukemia virus reverse transcriptase and a capsid protein primer did not produce a PCR product, suggesting that the RNA is of cellular origin (data not shown). Interestingly, treatment of the VLPs with RNase resulted in complete degradation of RNA, indicating that the RNA was bound on the exterior surface of the rSV capsids rather than in particles encapsidating the RNA (Fig. 3A) . It is also possible that the trace amounts of cellular RNA packaged into a small number of full particles could not be detected by ethidium bromide staining.
Trypsin digestion and MALDI-TOF analysis of rSV VLPs and soluble CP. Purified rSV particles were incubated with an equal volume of trypsin in serial twofold dilutions, beginning with the highest concentration of 500 g/ml, for 30 min at 37°C. Two predominant cleavage products were observed on SDS-PAGE (Fig. 4A) . MALDI-TOF analysis of the trypsintreated VLPs revealed the mean molecular masses of these two fragments to be 26.1 and 31.7 kDa (Fig. 4B and C) . To determine the exact sites of trypsinization, The VLPs were digested with trypsin, the proteolytic fragments were separated by gel electrophoresis, and the bands were transferred onto a PVDF membrane for N-terminal sequencing. Sequencing analysis of the first 10 amino acids of the 26.1-kDa cleavage product showed that the specific cleavage occurred at residue Arg307 of the rSV capsid protein (Fig. 5) . Further analysis of the mass spectral data by using the proteomics tool at http://prospector .ucsf.edu/ucsfhtml4.0/msdigest.htm suggested that the 26.1-kDa band corresponds to residues 308 to 544. The last four residues from the C terminus (residue 548) could have been cleaved prior to or after the cleavage at residue 307. For unknown reasons, N-terminal sequencing of the 31.7-kDa band did not give conclusive results. However, the analysis using the proteomics tool suggested that the 31.7-kDa band might have resulted from trypsin cleavage at residue Arg292, and it corresponds to residues 1 to 292, encompassing the S domain and partial P domain. Assuming that the latter result was correct, it explains the difficulties in obtaining the N-terminal sequence of the 31.7-kDa fragment, perhaps due to possible N-terminal modifications. Interestingly, both these cleavage sites, Arg292 and Arg307, are located in and around the 20-aa insertion in the P2 domain. Even though the proteomics tool suggested that the 29.3-kDa peak found in the MALDI-TOF spectra (Fig. 4C ) of the trypsin-digested soluble rSV coat protein corresponds to either residues 95 to 358 or 188 to 452, we did not further characterize this peak, as the corresponding band was not seen in SDS-PAGE or Western blot analysis.
To determine whether the 26.1-and 31.7-kDa bands were the result of trypsinization of intact VLPs or due to free subunits resulting from the disassembled capsids, SDS-PAGE and Western blot analysis of the peak fractions of the trypsin (62.5 g/ml)-digested VLPs separated through sucrose gradients were performed. The fractions from the top of the gradient resulted in a single (26.1-kDa) band, whereas the fractions from the middle of the gradients showed both the 26.1-kDa and 31.7-kDa bands ( Fig. 6A and B) . Observation of both fractions by EM revealed the presence of VLPs only in the middle fractions (Fig. 6C) . This clearly implies that the two (31.7-kDa and 26.1-kDa) bands are the result of trypsin digestion of the VLPs. Interestingly, the VLPs remain intact in sucrose for up to 72 h after undergoing trypsinization. On the other hand, trypsin digestion of the soluble rSV protein obtained by incubating VLPs in Tris buffer (pH 8.9) resulted in only the 26.1-kDa band at a lower concentration of trypsin ( Fig. 7A and B) . However, at a higher concentration of trypsin, the 26.1-kDa band was further cleaved to smaller peptides (data not shown).
Conservation of trypsin cleavage sites in human NoVs. Sequence alignment of these capsid proteins from various strains of NoVs suggested that approximately 48% of the amino acids in the S domain are conserved whereas fewer than 10% of the FIG. 3 . Native agarose gel electrophoresis of rSV VLPs, followed by ethidium bromide staining. (A) Lanes 1 to 3, purified rSV VLPs (1 g,amino acids are conserved in the P domain. The capsid protein of SV has 548 amino acid residues, whereas NV CP is composed of 530 amino acids. Alignment of these sequences revealed that the extra 18 aa present in the SV capsid protein resulted in a large insertion in the P2 domain (Fig. 8) . Prediction of trypsin cleavage sites in the amino acid sequence of SV coat protein by using a web-based tool (http://ca.expasy .org/tools/peptidecutter/) suggested that there are 35 trypsin cleavage sites in the SV sequence, compared to 25 in the NV capsid protein. Of these 25 sites, only 3 trypsin cleavage sites are present in the P2 domain (aa 278 to 405) of NV, whereas 12 of the 35 potential sites are present in the P2 domain of the SV capsid protein. These 12 trypsin cleavage sites are conserved among all members of GII.3. In addition, the arginine/lysine residue at position 287 (P2 domain) is conserved in all human NoVs sequenced to date (Fig. 8) . How- ever, based on the modeling studies, this residue does not appear to be accessible for trypsinization in the assembled form of the coat protein.
Homology modeling of the Sinsiro virus capsid protein and mapping of trypsin cleavage sites. A structural model of Sinsiro virus capsid protein was built using the Norwalk virus capsid protein as the structural template, as described in Materials and Methods section. The resulting model is nearly identical to that of Norwalk virus coat protein, with the exception of a 20-aa insertion (residues 297 to 316) in the P2 domain of the Sinsiro virus coat protein. This insertion forms a surfaceexposed loop in the assembled form of the coat protein (Fig.  9) . Furthermore, the two trypsin cleavage sites are either part of this loop (Arg307) or four residues upstream of the insertion (Arg292), and these residues are surface accessible, consistent with the results from trypsinization experiments. The third site (Arg544) at the C terminus was also found to be surface exposed. Interestingly, in addition to K227, a conserved trypsin cleavage site in the hinge region of NV, three potential trypsinization sites (K289, R291, and K391) in the P2 domain of NV do not appear to be surface accessible in the assembled (capsid) form of the particles.
DISCUSSION
Expression of rSV capsid protein in insect cells resulted in spontaneous formation of VLPs, which are morphologically similar to other NoV capsids. Examination of the purified VLPs under the transmission electron microscope revealed the presence of empty as well as a few full capsids. However, the ratio of empty to full capsids differed from one preparation to another. Even though the majority of the VLPs appeared to be empty under TEM, ethidium bromide staining of VLPs on native agarose gels indicated that there is RNA associated with the particles. However, RNase treatment of VLPs led to complete dissociation/degradation of the RNA, suggesting that the RNA is bound on the external surface of the VLPs (Fig. 3 ). This perhaps is made possible by the presence of clusters of positively charged amino acids exposed on the surface (Fig. 9) . However, it is also possible that the trace amounts of cellular RNA packaged into a very few full particles could not be detected by ethidium bromide staining. In addition, isolation of RNA associated with the VLPs followed by reverse transcription-PCR analysis showed that the RNA does not contain the viral message, and hence it might be of cellular origin.
The results obtained from in vitro trypsin digestion of the intact VLPs followed by N-terminal sequencing and mass spectrometry analysis suggested that the trypsin cleavage sites are located at amino acid residues Arg292, Arg307, and Arg544. Interestingly, two of these residues (Arg292 and Arg307) are located in and around the large insertion of 20 aa in the P2 domain, while the third site, Arg544, is located near the C terminus. Homology modeling studies clearly indicated that this insertion is unstructured and surface exposed, thus facilitating the ease of trypsinization at these three sites (Fig. 9) . There is another conserved basic residue (R296) in this loop, which has potential to be trypsinized. However, further proteolysis at residues R292 and R307 on either side of R296 could release the short peptides of residues 293 to 296 and 297 to 306. Hence, the cleavage at residue R296 may not have a significant impact. Remarkably, the large insertion of 20 aa (relative to NV) appears to be a characteristic of the GII.3 and GII.6 NoVs along with the conservation of all three trypsin cleavage sites, implying a potential biological role for this insertion. Earlier studies by Hardy et al. suggested that NV particles are resistant to trypsinzation (18) . They have also shown that the free coat protein subunits undergo trypsinization, thereby releasing the intact P domain. Our results are in good agreement with those of Hardy et al., as the GI.1 NoVs (e.g., Norwalk virus) lack the large surface insertion as seen in the GII.3 viruses (e.g., Sinsiro virus) and none of other basic residues are available for trypsinization in the particle form, except for the cluster of arginines near the C terminus. Hence, the group I NoVs may not undergo trypsinization in the assembled form to release the intact P domain. However, the above results do not support the recent findings reported by Tan et al. (36) , who suggested that the NV (GI) and VA387 (GII.4) particles, both of which lack the long insertion (only a 12-aa insertion in the case of VA387) comprised of basic amino acids, undergo partial trypsin digestion, thereby releasing the intact P domains. This is a rather surprising finding, as Lys227 in NV or its counterparts near the hinge regions of other NoVs, which need to be proteolysed to release the P domain, are in fact buried and would be inaccessible for trypsinization in all the intact norovirus capsids. This site would become accessible for trypsinization only in the free and soluble form of the CP subunits or at minimum in the disassembled and/or partially assembled forms of capsids.
Sinsiro virus has 12 trypsin cleavage sites (Arg287, Arg292, Arg296, Arg307, Arg341, Lys343, Arg351, Arg358, Lys363, Arg370, Lys374, and Arg394) in the P2 domain. Based on the trypsin digestion experiments and modeling studies, the trypsin cleavage sites at Arg292 and Arg307 are accessible to trypsinization even in the assembled VLPs. In contrast, there are only three potential trypsin cleavage sites (Lys289, Arg291, and Lys391) present in the P2 domain of NV. Based on modeling studies, all these sites appeared to be buried, except for residue Lys391, which is partially exposed. However, none of these sites have been reported to be accessible for trypsin digestion in the assembled form of Norwalk virus (18, 36) .
Remarkably, TEM characterization of the trypsin-treated rSV particles revealed that the VLPs remain intact even after trypsin digestion (Fig. 6C) . The cleaved fragments remain associated with the rest of capsid, perhaps due to close interactions between the P domains up to 72 h after trypsin treatment. Trypsin digestion of the soluble capsid protein of SV obtained by disassembly of VLPs showed a single 26.1-kDa fragment (aa 308 to 544) of the P domain, which is resistant to further proteolysis at low concentrations of trypsin (Fig. 6 ). This clearly shows that Arg307 is accessible for trypsinization in both the assembled and unassembled forms of the Sinsiro virus coat protein subunits. However, higher concentrations of trypsin led to complete degradation of SV capsid protein (data not shown). We surmise that the 31.7-kDa fragment in its unassembled form is digested into smaller fragments even at low concentrations of trypsin.
Earlier studies suggested that the hypervariable region of the P2 domain (aa 300 to 405) of NV is the main region where immune response-driven mutations are localized (26) . In addition, the P2 domain also contains the determinants for strain specificity (29) . Moreover, monoclonal antibodies that recognize residues 300 to 384 in the P2 domain readily inhibit the binding of NV capsids to cells (39) . Several studies using recombinant peptides and domain swaps have shown that the neutralization epitopes in feline calicivirus also map to the hypervariable region in the P2 domain (37) . Recently, Lochridge et al. further narrowed down the antigenic epitopes to amino acids 291 to 293 and 313 to 322 in the P2 domains of NV and Snow Mountain virus, which are the reference strains of GI.1 and GII.2, respectively (23) . The linear epitope composed of amino acids 313 to 322 in Snow Mountain virus, which has been suggested to be responsible for the host cell interactions, is conserved among all the NoVs (23) . Remarkably, the corresponding residues 325 to 334 in SV remain contiguous even after trypsin digestion, suggesting that the trypsin-treated particles, in principle, are capable of binding to cells.
For viruses that replicate on mucosal surfaces and particularly in the gastrointestinal tract, proteolytic cleavage of outer capsid proteins plays an important role in the replication cycle of the parent viruses. Previous studies on rotaviruses clearly indicated that the trypsin cleavage of the outer capsid protein leads to a severalfold increase in infectivity (11) . We hypothesize that the proteolytic cleavage of SV capsids at residues R292 and R307 results in less restraint on residues 325 to 334, thereby enhancing their ability to bind cells. This perhaps could be one of the reasons for greater virulence of Sinsiro virus and GII.3 NoVs in general, as well as GII.6 NoVs. In addition, the proteolytic cleavage may also promote the viral infection by inhibiting the binding of neutralizing antibodies against the native virus to the "nicked" virus.
